Comparison
Saffron vs Reishi
Saffron
Crocus stigma — most expensive spice. Increasingly evidence-based antidepressant comparable to SSRIs at low doses.
Reishi
Medicinal mushroom (Ganoderma lucidum) traditionally used for sleep, immunity, and longevity.
| Field | Saffron | Reishi |
|---|---|---|
| Category | adaptogen | adaptogen |
| Dose range | 28–30mg | 1000–3000mg |
| Half-life | — | — |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEB |
| Safety | ●●●●○ | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 1700 | 460 |
The comparison in plain English
Auto-generated from dataSaffron and Reishi are both in the adaptogen category respectively. Saffron Crocus stigma — most expensive spice. Reishi Medicinal mushroom (Ganoderma lucidum) traditionally used for sleep, immunity, and longevity.
Bottom line
Saffron (evidence A, safety 4/5) has a weaker evidence base than Reishi (evidence B, safety 5/5). Reishi has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Saffron if
Saffron is the better fit when your goal aligns with its mechanism (Crocin (carotenoid responsible for the red colour) and safranal (volatile compound responsible for the aroma) both inhibit serotonin and dopamine reuptake at neurochemically meaningful concentrations) and the dose range (28–30mg) suits your protocol. Half-life is —h.
Choose Reishi if
Reishi is the better fit when your goal aligns with its mechanism (Beta-glucans (the polysaccharide fraction) modulate innate and adaptive immunity through TLR-4 receptor binding) and the dose range (1000–3000mg) suits your protocol. Half-life is —h.